PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
19-Apr-2023 Kromek and Analogic Announce Collaboration Agreement to Develop Next Generation Computed Tomography (CT) Detector Technology Kromek Group plc
19-Apr-2023 Zymeworks Presents New Data From Multiple Preclinical And Clinical Development Programs At The 2023 American Association For Cancer Research Annual Meeting Zymeworks
19-Apr-2023 ALMADEN GENOMICS UPDATES G.NOME PLATFORM WITH JUPYTER NOTEBOOK INTEGRATION Almaden Genomics
19-Apr-2023 Maxion Therapeutics Awarded £2 Million Innovate UK Funding to Develop Ion Channel Antibodies for “Hard-To-Treat" Autoimmune Diseases B3C newswire
19-Apr-2023 Cannovum AG develops cultivation kits for Cannabis Social Clubs Cannovum AG
19-Apr-2023 Biophytis regains compliance with NASDAQ minimum bid price requirement Biophytis
19-Apr-2023 Grünenthal GmbH: Grünenthal announces pricing of €300 million bond Grünenthal GmbH
19-Apr-2023 Marinomed Biotech AG with Carragelose record sales in 2022 and positive outlook for 2023 Marinomed Biotech AG
19-Apr-2023 PharmaSGP plans dividend distribution of 49.2% after record year in 2022 PharmaSGP Holding SE
18-Apr-2023 Gerresheimer AG: Gerresheimer AG successfully completes EUR 271.6 million capital increase Gerresheimer AG
18-Apr-2023 Gerresheimer AG: Gerresheimer AG issues 3,140,000 million new shares at a placement price of EUR 86.50 per new share Gerresheimer AG
18-Apr-2023 Abivax appoints Michael Ferguson as Chief Commerical Officer ABIVAX
18-Apr-2023 Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares Gerresheimer AG
18-Apr-2023 Gerresheimer AG: Gerresheimer AG launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding by up to 3,140,000 shares Gerresheimer AG
18-Apr-2023 Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting Evolva Holding SA
18-Apr-2023 Sygnature Discovery and Daewoong Pharma announce drug discovery research collaboration Sygnature Discovery
18-Apr-2023 Kinnate Biopharma Inc. Adds Two New Drug Candidates to Its Growing Targeted Oncology Pipeline and Provides Cash Runway Guidance Kinnate Biopharma Inc.
18-Apr-2023 First Report of Positive Dose Escalation Data Supports Best-in-Class Profile for Investigational Exarafenib as a Single Agent and in Combination with Binimetinib in BRAF-altered Cancers and NRAS Mutant Melanoma Kinnate Biopharma Inc
18-Apr-2023 CureVac to Report Fourth Quarter and Full-Year 2022 Financial Results and Business Updates on April 25, 2023 CureVac
18-Apr-2023 Myricx Pharma Presents Positive Pre-clinical PoC Data at AACR for its N-Myristoyltransferase inhibitor (NMTi) ADC Programme Alongside New Biology on Novel MoA for NMTi Myricx Pharma